Takafumi Komiyama
Overview
Explore the profile of Takafumi Komiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, Notsu A, et al.
J Palliat Med
. 2024 Dec;
28(1):42-49.
PMID: 39729365
Utility values of responders and nonresponders are essential inputs in cost-effectiveness studies of radiation therapy for painful bone metastases but, to our knowledge, they have not been reported separately. We...
2.
Utsumi N, Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, et al.
Jpn J Clin Oncol
. 2024 Oct;
55(2):140-147.
PMID: 39479804
Objective: Single-center studies or randomized controlled trials have evaluated the impact of radiotherapy for bone metastases on quality of life (QOL). We investigated the real-world impact of radiotherapy for bone...
3.
Matsuda M, Komiyama T, Marino K, Aoki S, Akita T, Sano N, et al.
Thorac Cancer
. 2024 Oct;
15(33):2365-2374.
PMID: 39392105
Background: We investigated the clinical outcomes of involved-field high-dose (≥66 Gy) chemoradiotherapy (CRT) combined with respiratory motion management for esophageal squamous cell carcinoma (ESCC). Methods: Patients who underwent definitive CRT...
4.
Harada H, Shikama N, Notsu A, Shirato H, Yamada K, Uezono H, et al.
J Radiat Res
. 2024 Aug;
65(5):701-711.
PMID: 39162649
Purpose of this study is to evaluate patient characteristics, treatments and outcomes in bone metastasis radiotherapy practice. Patients for whom radiotherapy for bone metastasis was planned at 26 institutions in...
5.
Matsuda M, Ichikawa J, Komiyama T, Onohara K, Saito M, Nemoto H, et al.
Thorac Cancer
. 2024 Aug;
15(26):1912-1916.
PMID: 39113470
Although stereotactic body radiotherapy (SBRT) is a curative treatment option for stage I non-small cell lung cancer (NSCLC), limited data are available regarding chest wall (CW) toxicities during an extended...
6.
Saito M, Ueda K, Nemoto H, Onishi Y, Suzuki H, Suzuki T, et al.
J Appl Clin Med Phys
. 2024 May;
25(8):e14381.
PMID: 38696715
Background: Surface-guided radiotherapy (SGRT) is adopted by several institutions; however, reports on the phantoms used to assess the precision of the SGRT setup are limited. Purpose: The purpose of this...
7.
Nemoto H, Saito M, Satoh Y, Komiyama T, Marino K, Aoki S, et al.
J Appl Clin Med Phys
. 2024 Mar;
25(7):e14322.
PMID: 38436611
Purpose: Predicting recurrence following stereotactic body radiotherapy (SBRT) for non-small cell lung cancer provides important information for the feasibility of the individualized radiotherapy and allows to select the appropriate treatment...
8.
Saito M, Komiyama T, Marino K, Aoki S, Akita T, Matsuda M, et al.
Thorac Cancer
. 2023 Oct;
14(35):3445-3452.
PMID: 37846145
Background: The purpose of this study was to compare the dosimetric characteristics of five different treatment planning techniques for locally advanced non-small cell lung cancer (LA-NSCLC) with sequential plan changes....
9.
Saito T, Shikama N, Takahashi T, Harada H, Ueno S, Notsu A, et al.
Br J Radiol
. 2023 Sep;
96(1151):20230351.
PMID: 37750858
Objective: To identify factors significantly associated with quality of life (QOL) and determine if these associations are strong enough to predict certain aspects of QOL without measuring them. Methods: We...
10.
Onishi H, Shioyama Y, Matsumoto Y, Matsuo Y, Miyakawa A, Yamashita H, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686657
Surgery is the standard treatment for stage I non-small cell lung cancer (NSCLC); however, no clear randomized trial demonstrates its superiority to stereotactic body radiotherapy (SBRT) regarding survival. We aimed...